All In MedTech

FDA Clearance Tracker · P120020-S001

SUPERA PERIPHERAL STENT SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 30, 2014 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P120020-S001
Device name
SUPERA PERIPHERAL STENT SYSTEM
Applicant location
Santa Clara, CA
Received
Mar 31, 2014
Decided
Apr 30, 2014
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P120020

Device type

Device class
Class III

Every decision under product code NIP

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE LOCATED AT STERIGENICS IN LOS ANGELES, CALIFORNIA.

Source documents

Other decisions for Abbott Vascular (Idef Technologies Inc)

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.